Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
---|---|---|---|---|---|---|---|---|---|---|
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 775,3 T ARS | 14,450 USD | +2,85% | 418 | 0,87 | 112,15 | 124,85 ARS | +178,70% | 0,32% | — |
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 775,3 T ARS | 16 650,000 ARS | +0,30% | 1,68 K | 0,25 | 133,36 | 124,85 ARS | +564,33% | 0,32% | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 358,72 T ARS | 9,890 USD | +0,30% | 931 | 0,44 | 31,22 | 306,92 ARS | +50,08% | 1,73% | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 358,72 T ARS | 1 300,000 ARS | 0,00% | 15 | 1,90 | — | — | — | — | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 358,72 T ARS | 11 425,000 ARS | +0,88% | 6,66 K | 0,15 | 37,22 | 306,92 ARS | +257,75% | 1,73% | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 323,32 T ARS | 18,100 USD | 0,00% | 57 | 0,40 | 7,48 | 2 343,37 ARS | +18,73% | 1,69% | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 323,32 T ARS | 21 100,000 ARS | +1,32% | 426 | 0,62 | 9,00 | 2 343,37 ARS | +183,01% | 1,69% | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 257,82 T ARS | 20,950 USD | +0,96% | 5 | 0,09 | 22,98 | 883,37 ARS | +319,19% | 1,49% | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 257,82 T ARS | 23 375,000 ARS | +0,32% | 387 | 0,22 | 26,46 | 883,37 ARS | +899,22% | 1,49% | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 207,68 T ARS | 33,600 USD | +1,36% | 30 | 2,46 | 48,03 | 677,80 ARS | +64,44% | 1,47% | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 207,68 T ARS | 38 850,000 ARS | −0,32% | 763 | 0,54 | 57,32 | 677,80 ARS | +291,99% | 1,47% | — |
TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1 DR | 206,08 T ARS | 28 000,000 ARS | +1,17% | 281 | 0,06 | 50,09 | 558,94 ARS | +251,94% | 0,14% | — |
ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 203,35 T ARS | 27,750 USD | −6,25% | 14 | 0,73 | 42,68 | 629,98 ARS | +55,55% | 0,93% | — |
ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 203,35 T ARS | 33 725,000 ARS | +1,05% | 139 | 0,50 | 53,53 | 629,98 ARS | +270,79% | 0,93% | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 198,1 T ARS | 28 800,000 ARS | −0,17% | 60 | 0,13 | 3,32 | 8 672,72 ARS | +474,20% | 3,76% | — |
ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORD DR | 192,6 T ARS | 7 000,000 ARS | +0,14% | 4 | 0,08 | 132,35 | 52,89 ARS | +386,62% | 0,00% | — |
DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORD DR | 169,76 T ARS | 5 160,000 ARS | +4,67% | 9 | 0,04 | 69,95 | 73,76 ARS | +137,74% | 0,00% | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 155,25 T ARS | 6,810 USD | +0,59% | 505 | 0,19 | 28,11 | 234,71 ARS | +35,96% | 3,18% | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 155,25 T ARS | 7 870,000 ARS | +1,16% | 3,15 K | 0,10 | 33,53 | 234,71 ARS | +224,10% | 3,18% | — |
AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 145,55 T ARS | 8,500 USD | −2,86% | 45 | 0,89 | 33,07 | 249,09 ARS | −66,41% | 2,40% | — |
AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 145,55 T ARS | 10 300,000 ARS | +0,73% | 400 | 0,41 | 41,35 | 249,09 ARS | −19,94% | 2,40% | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119,78 T ARS | 22 475,000 ARS | +0,11% | 186 | 0,43 | — | −1 078,84 ARS | −466,33% | 2,06% | — |
GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 119,39 T ARS | 24,500 USD | +2,94% | 4 | 0,24 | — | −50,65 ARS | −107,71% | 1,56% | — |
GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 119,39 T ARS | 27 500,000 ARS | +0,73% | 169 | 0,53 | — | −50,65 ARS | −118,38% | 1,56% | — |
MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1 DR | 107,05 T ARS | 23 925,000 ARS | +0,31% | 181 | 0,44 | 35,58 | 672,48 ARS | +274,72% | 1,95% | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 69,97 T ARS | 8,640 USD | +0,47% | 1 | 0,01 | 27,20 | 307,84 ARS | −37,30% | 3,32% | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 69,97 T ARS | 9 990,000 ARS | +0,60% | 88 | 0,07 | 32,45 | 307,84 ARS | +49,45% | 3,32% | — |
PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADR DR | 24,22 T ARS | 5 980,000 ARS | +0,67% | 136 | 0,72 | — | −689,04 ARS | −3,81% | 0,00% | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 22,33 T ARS | 11,450 USD | −3,78% | 2 | 0,15 | 15,95 | 695,64 ARS | +96,62% | 0,00% | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 22,33 T ARS | 13 400,000 ARS | −0,74% | 172 | 0,24 | 19,26 | 695,64 ARS | +368,68% | 0,00% | — |
MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 15,63 T ARS | 2,140 USD | −1,83% | 13 | 0,07 | — | −262,17 ARS | +31,39% | 0,00% | — |
MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 15,63 T ARS | 2 450,000 ARS | +2,08% | 47 | 0,01 | — | −262,17 ARS | −63,54% | 0,00% | — |
RICHLABORATORIOS RICHMOND SACIF | 143,33 B ARS | 1 790,000 ARS | +0,85% | 2,45 K | 0,19 | 18,59 | 96,29 ARS | — | 0,00% | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,93 B ARS | 115,750 ARS | −3,54% | 3,9 K | 0,39 | 27,12 | 4,27 ARS | +64,50% | 0,00% | — |